📰 Total Identity News
Total Identity News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Total Identity. Real-time updates on events, politics, business and more.
October 5, 2023
StockNews.com assumed coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a research note issued to investors on Monday morning. The brokerage issued a hold rating on the medical instruments supplier’s stock. Conformis Stock Performance CFMS stock opened at $2.26 on Monday. The company has a market cap of $17.80 million, a P/E ratio […]
September 25, 2023
StockNews.com assumed coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a research report report published on Sunday morning. The brokerage issued a hold rating on the medical instruments supplier’s stock. Conformis Stock Performance Shares of NASDAQ CFMS opened at $2.26 on Friday. The business has a 50 day simple moving average of $2.25 […]
September 20, 2023
StockNews.com assumed coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a research note published on Saturday morning. The firm issued a hold rating on the medical instruments supplier’s stock. Conformis Price Performance Shares of NASDAQ:CFMS opened at $2.26 on Friday. The company has a current ratio of 5.07, a quick ratio of 3.30 […]
September 12, 2023
StockNews.com began coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a research note published on Friday. The brokerage issued a hold rating on the medical instruments supplier’s stock. Conformis Price Performance Shares of NASDAQ CFMS opened at $2.26 on Friday. Conformis has a 52 week low of $1.05 and a 52 week high […]
September 4, 2023
StockNews.com initiated coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a report published on Thursday morning. The firm issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer lowered shares of Conformis from an outperform rating to a market perform rating in a research note on Tuesday, May 9th. Get Our […]
September 2, 2023
Investment analysts at StockNews.com initiated coverage on shares of Conformis (NASDAQ:CFMS – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the medical instruments supplier’s stock. Separately, Oppenheimer downgraded shares of Conformis from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May […]
August 27, 2023
StockNews.com assumed coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a research report report published on Wednesday morning. The brokerage issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer cut Conformis from an outperform rating to a market perform rating in a research note on Tuesday, May 9th. View Our […]
August 19, 2023
StockNews.com assumed coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a research report report published on Tuesday morning. The firm issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer lowered Conformis from an outperform rating to a market perform rating in a research report on Tuesday, May 9th. View Our […]
August 10, 2023
StockNews.com assumed coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a research report report published on Monday. The firm issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer lowered Conformis from an outperform rating to a market perform rating in a research note on Tuesday, May 9th. View Our Latest […]
August 3, 2023
StockNews.com began coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a research note issued to investors on Sunday. The brokerage issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer cut Conformis from an outperform rating to a market perform rating in a research note on Tuesday, May 9th. View Our […]